Fallon, P.G. and Lavin, M. and O'Donnell, J.S., SIPPET: insights into factor VIII immunogenicity, Journal of Thrombosis and Haemostasis, 16, (1), 2018, p36-38 ,
Notes: [cited By 0],
Journal Article,
PUBLISHED
DOI
|
Mcdonnell, C.J. and Soule, E.E. and Walsh, P.T. and O'donnell, J.S. and Preston, R.J.S., The Immunoregulatory Activities of Activated Protein C in Inflammatory Disease, Seminars in Thrombosis and Hemostasis, 2018, p167 - 175,
Journal Article,
PUBLISHED
DOI
|
O'sullivan, J.M. and Preston, R.J.S. and Robson, T. and O'donnell, J.S., Emerging Roles for von Willebrand Factor in Cancer Cell Biology, Seminars in Thrombosis and Hemostasis, 2017,
Notes: [cited By 0; Article in Press],
Journal Article,
PUBLISHED
DOI
|
Gleeson, E.M. and McDonnell, C.J. and Soule, E.E. and Willis Fox, O. and Rushe, H. and Rehill, A. and Smith, O.P. and O'Donnell, J.S. and Preston, R.J.S., A novel protein Câ"factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling, Journal of Thrombosis and Haemostasis, 15, (11), 2017, p2198-2207 ,
Notes: [cited By 0],
Journal Article,
PUBLISHED
DOI
|
Brophy, T.M. and Ward, S.E. and McGimsey, T.R. and Schneppenheim, S. and Drakeford, C. and O'Sullivan, J.M. and Chion, A. and Budde, U. and O'Donnell, J.S., Plasmin cleaves von willebrand factor at K1491-R1492 in the A1-A2 linker region in a shear- and glycan-dependent manner in vitro, Arteriosclerosis, Thrombosis, and Vascular Biology, 37, (5), 2017, p845-855 ,
Notes: [cited By 3],
Journal Article,
PUBLISHED
DOI
|
Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, O'Neill D, Murphy SJ, Lim SJ, Murphy RP, McCabe DJH, Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes., J Neurol Sci, 375, 2017, p404 - 410,
Journal Article,
PUBLISHED
DOI
URL
|
Lavin, M. and Ryan, K. and White, B. and Byrne, M. and O'Connell, N.M. and O'Donnell, J.S., A role for intravenous immunoglobulin in the treatment of Acquired Von Willebrand Syndrome associated with IgM gammopathy, Haemophilia, 2017, pe22-e25 ,
Journal Article,
PUBLISHED
DOI
|
O'Sullivan J., O'Sullivan J., Aguila S., Aguila S., McRae E., Ward S., Ward S., Rawley O., Fallon P., Brophy T., Brophy T., Preston R., Preston R., Brady L., Sheils O., Chion A., Chion A., O'Donnell J., O'Donnell J., O'Donnell J., N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor, Journal of Thrombosis and Haemostasis, 14, (12), 2016, p2446-2457 ,
Journal Article,
PUBLISHED
DOI
|
Chion A, O'Sullivan JM, Drakeford C, Bergsson G, Dalton N, Aguila S, Ward S, Fallon PG, Brophy TM, Preston RJ, Brady L, Sheils O, Laffan M, McKinnon TA, O'Donnell JS., N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance., Blood, 128, (15), 2016, p1959-1968 ,
Journal Article,
PUBLISHED
DOI
|
Collins, P. and Chalmers, E. and Chowdary, P. and Keeling, D. and Mathias, M. and O'Donnell, J. and Pasi, K.J. and Rangarajan, S. and Thomas, A., The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO, Haemophilia, 22, (4), 2016, p487-498 ,
Notes: [cited By 17],
Journal Article,
PUBLISHED
DOI
|
|